Related Experiment Video
Updated: Jul 15, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Sedation and analgesia in the critically ill adult
Gilles L Fraser1, Richard R Riker
1Division of Pulmonary and Critical Care Medicine, Maine Medical Center, Portland, ME 04102, USA. fraseg@mmc.org
Purpose Of Review:
To review the recent advances in providing analgesia and sedation to intensive care unit patients that can improve outcomes, and reduce resource utilization and adverse events.
Recent Findings:
Validated tools to assess patient sedation and analgesia are available, and have been shown to improve outcomes when used. A strategy providing analgesia-first and supplemented by sedation-as-needed appears to improve patient outcomes. The negative impact of deep sedation to the point of coma, even for brief periods, is again recognized. Additional data defining adverse events associated with propofol and lorazepam can help us develop strategies to avoid them.
Summary:
Utilizing and incorporating these new advances can improve outcomes and result in a more comfortable patient.
Related Concept Videos
Parenteral Anesthetics: Overview
Stages of General Anesthesia
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Inhalational Anesthetics: Overview